decreased susceptibility to hepatic steatosis_Sertad2<Gt(OST98734)Lex>/Sertad2<Gt(OST98734)Lex>

http://metadb.riken.jp/0002310B6129S5Sertad2GtOST98734LexSertad2GtOST98734LexSertad2GtOST98734LexSertad2GtOST98734Lex

decreased susceptibility to hepatic steatosis_Sertad2<Gt(OST98734)Lex>/Sertad2<Gt(OST98734)Lex>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• SERTA domain containing 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:1931026

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Sertad2<Gt(OST98734)Lex>/Sertad2<Gt(OST98734)Lex>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Sertad2<Gt(OST98734)Lex>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• B6.129S5-Sertad2<Gt(OST98734)Lex>

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased susceptibility to hepatic steatosis
  http://purl.obolibrary.org/obo/MP_0002310

文献

http://purl.org/net/cito/citesAsAuthority

• Chong Wee. Liew, et.al., Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance., Nature medicine, 2013, 19
  http://rdf.ncbi.nlm.nih.gov/pubmed/23291629